ClinicalTrials.gov record
Completed Phase 2 Interventional

D-MPH in the Treatment of Fatigue and Neurobehavioral Function Related to Chemotherapy in Adult Cancer Patients

ClinicalTrials.gov ID: NCT00047476

Public ClinicalTrials.gov record NCT00047476. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 10:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of d-MPH in the Treatment of Fatigue and Neurobehavioral Impairment Related to Chemotherapy in Adult Cancer Patients

Study identification

NCT ID
NCT00047476
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Celgene Corporation
Industry
Enrollment
160 participants

Conditions and interventions

Interventions

  • dexmethylphenidate(d-mph) Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2002
Primary completion
Not listed
Completion
Feb 29, 2004
Last update posted
Jun 23, 2005

2002 – 2004

United States locations

U.S. sites
21
U.S. states
11
U.S. cities
20
Facility City State ZIP Site status
Cooper Green Hospital, Jefferson Clinic Birmingham Alabama 35233
University of Alabama Palliative Care Institute Birmingham Alabama 35294-0023
Peak Performance Wellness Flagstaff Arizona 86004
Arizona Clinical Research Center Tucson Arizona 85712
Alta Bates Comprehensive Cancer Center Berkeley California 94704
California Cancer Care Inc Greenbrae California 94904-2007
Clinical Trials and Research Associates Montebello California 90640
Comprehensive Cancer Centers of the Desert Palm Springs California 92262
Comprehensive Cancer Center Boca Raton Florida 33428
Osler Clinical Research/Osler Medical Inc Melbourne Florida 32901
University of Miami, Sylvester Cancer Research Center Miami Florida 33139
Cancer Research Network Inc Plantation Florida 33324
H. Lee Moffitt Cancer Center and Research Institute Tampa Florida 33162
Piedmont Hospital Atlanta Georgia 30309
Markey Cancer Center Lexington Kentucky 40536
Sinai Hospital of Baltimore Baltimore Maryland 21215
Beth Israel Cancer Center New York New York 10003
Gynecologic Oncology Associates and Development LLC Greenville South Carolina 29604
Seattle Cancer Care Alliance Seattle Washington 98109-1023
Northwest Medical Specialists, PLLC Tacoma Washington 98405
UW Comprehensive Cancer Center Madison Wisconsin 53792-6164

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00047476, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 23, 2005 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00047476 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →